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Inductionof cell activation is usuallythe consequenceof an interactionbetween
specific surface receptors and their ligands (1). The natural ligand involved in T
cell activation is the molecular complex formed by a foreign antigen and self
MHC products on the surface of antigen-presenting cells. The surface TCR for
the antigen/MHC complex is a heterodimeric molecule (carrying variable por-
tions, Ti) that is linked to theCD3 molecule (2) . T cell activation canbe artificially
induced by the use of mAbs directed to CD3-TCR molecules (3) or to another
surface glycoprotein, termed CD2 (4, 5), which is not physically associated with
the CD3-TCR complex . Following interaction with specific mAbs, both CD3-
TCR (2) and CD2 (5) molecules undergo surface capping followed by their
persistent (48-72 h) disappearance (also termed modulation) . As a consequence,
T cells become refractory to further stimulation with mAbs of thesame specificity
(2, 5) . Receptor modulation by specific ligandsand subsequent cell refractoriness
to stimuli mediated by the same ligand is a general phenomenon described in
many cell types for a variety of surface receptors (6) . In contrast, antibody-
induced modulation ofCD3-TCR receptor complex (but not ofCD2 molecules)
results in a general cell unresponsiveness that is not restricted to the CD3-TCR
activation pathway (5) . While the inhibitory effect resulting from modulation of
CD3-TCR molecules has been assessed by analyzing different T cell functions,
including CTL activity and lymphokine production, little is known about the
actual level and mechanism of inhibition . Here we show that the early metabolic
steps, such as increase in free cytoplasmic Ca" concentration ([Ca2+ ]i) and
inositol-3-phosphate (InsP3) formation, which usually follow receptor-ligand in-
teractions, are inhibited in CD3-TCR-modulated cells . In addition, evidence is
provided that this inhibition involves, at least in part, G proteins .
Material and Methods
Cells.
￿
TheJA3 cloned cell line was derived by mutagenesis from the IL-2 producing
Jurkat T-ALL by exposing these cells to gamma radiation (Cs source) (7) .
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Monoclonal Antibodies.
￿
mAb with specificity for the CD3 molecule and for the antigen
receptor molecule expressed on JA3 cells were derived as previously described (11). Anti-
CD2 mAb (CD2 .1 and CD2.9), which in combination induce in JA3 cells an increase of
[Ca2+]; and InSP3 were derived as previously described (8).
Flow Cytofuorometric Analysis.
￿
The techniques used have been described in detail
elsewhere (9). Briefly, 2 x 105 JA3 cells were stained with the appropriate mAb followed
by goat anti-mouse Ig. Control aliquots were stained with the fluorescent reagent alone.
All samples were then analyzed on a flow cytometer (FACS II ; Becton Dickinson Immu-
nocytometry Systems, Mountain View, CA) gated to exclude nonviable cells. Results are
expressed as arbitrarily normalized histograms, i.e., number of cells vs. fluorescence
intensity.
Modulation Experiments. Surface modulation of CD3-TCR or CD2 molecules was
achieved by incubating JA3 cells for 24 h at 37°C in the presence of saturating concen-
trations of mAbs as described (5). To ensure the actual modulation of the various surface
antigens, modulated and unmodulatedJA3 cells were stained with appropriate anti-CD3,
anti-TCR, or anti-CD2 mAbs and fluoresceinated second reagent, and analyzed on a flow
cytometer. Only when fluorescence intensity was reduced by >90%, were JA3 cells further
used in these studies.
Determination of (Ca"] ; . Determination of [Ca"] ;was performed as previously de-
scribed (8). Briefly, JA3 cells were loaded with the acetoxymethyl ester of Fura-2 (1 PM,
final concentration) (Molecular Probes, Inc., Junction City, OR) and the fluorescence of
the cellular suspension (5 x 106 cells per 2 ml) was monitored with a Perkin-Elmer LS-5
spectrofluorimeter using 2-ml quartz cuvette. The cell suspension was excited at 340 nm,
and fluorescence was measured at 510 run. Five slit widths were used for both excitation
and emission. All measurements were performed at 37°C using a thermostatically con-
trolled cuvette holder and stirring apparatus. [Ca21], calculated by the method of Gryn-
kiewicz et al. (10) is displayed on the vertical axis. When the stimulus was provided by
AIF4- , a mixtureof NaF (10 mM final concentration) and AICIs(25AM finalconcentration)
was added. Mn21 was used at 25 AM, final concentration.
Measurements of [6H]Inositol Phosphates.
￿
Measurements of inositol phosphates were
performed as previously described (8, 11). Briefly, incorporation of [6H]myoinositol into
phospholipid was achieved by incubating JA3 cells (107 cells/ml) in a Hepes-buffered
saline solution with 30 ACi of [5H]myoinositol (37 MBq/ml; Amersham Corp., Arlington
Heights, IL) for 3 h at 37°C, followed by extensive washing, resuspension at 107 cells/ml
in the labellingsolution, and incubation for additional 60 min at 37 °C. Aliquots (1 ml) of
this cellular suspension were then transferred to microfuge tubes and the appropriate
additions were made. Monoclonal antibodies were added to a final dilution of 1:400 of
ascites fluid. When the stimulus was provided by AIF4-, a mixture of NaF (10 mM, final
concentration) and AICIs (25 AM, final concentration) was added. Cells were then sedi-
mented in an Eppendorf 5414 centrifuge. The reaction was stopped by adding chloro-
form/methanol (1 :2). The phases were separated by the addition of 0.25 ml H2O and
0.25 ml chloroform, and the upper phase was transferred to a borosilicate tube containing
5.5 ml H2O. This diluted aqueous phase (^-6 ml) was mixed with 300 Al of 100 mM
disodium tetraborate (5 mM,finalconcentration) andstored on ice until analyzed. Extracts
were subjected to ion-exchange chromatography using Dowex 1-x8 anion-exchange resin
(Bio-Rad Laboratories, Richmonds, CA)in formateform (1 .2 ml packed resinper column).
The radioactivity of the various elution fractions was quantified by scintillation counting
in Aquassure (New England Nuclear, Boston, MA). This method does not allow one to
distinguish among various possible form or isomers of InsPS.
Treatment ofJA3 Cells with Cholera Toxin.
￿
JA3 cells (5 x 106 cells/ml) were incubated
at 37°C for 3 h in medium alone or in the presence of 0.2 Ag/ml of cholera toxin. After
incubation JA3 cells were washed twice with cold medium and used for Ca" measure-
ments.300
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FIGURE 1 .
￿
Effect of modulation of either CD3-TCR or CD2 molecules on the [Ca21],
increments induced by stimuli acting via one or another activation pathway . Unmodulated
JA3 cells stimulated with either anti-TCR (A) or anti-CD2 mAbs (D) . CD3-TCR modulated
JA3 cells stimulated with anti-TCR (B)andanti-CD2 (C) . CD2 modulatedJA3 cells stimulated
with anti-TCR (E) and anti-CD2 (F) . The cells were placed in the fluorimeter and stimulated
with either a stimulatory combination (8, 12) of anti-CD2 mAb (1 :800 of ascites fluid) or anti-
TCR mAb (12) (1 :800 of ascites fluid). The tracings are representative of 10 separate
experiments . The different stimuli were added in the presence of 1 mM extracellular Cat+.
Arrows indicate the time of addition of the stimuli . The inset photograph (right) shows that
mAb-induced modulation of CD3-TCR complex did not affect surface expression of CD2
antigen. (1) TCR and (II) CD2 expression in unmodulatedJA3 cells . III and IV: TCR and
CD2 expression inJA3 cells modulated with anti-TCR mAb .
Results and Discussion
In these studies we used as indicator cell system the JA3 cloned lymphocytic
line, derived from the IL-2 producing Jurkat T cell leukemia . JA3 cells have
been previously shown to release IL-2 following stimulation via either the CD3-
TCR or the CD2 molecules (5, 7) . The signal transducing mechanisms used in
the CD2 pathway were found to be undistinguishable from those used in the
CD3-TCR pathway (15) . The experiments shown in Fig . 1 were designed to
analyze the effectof either CD3-TCR or CD2 modulation on the [Ca2+];increase
induced by either mAb . After CD3-TCR modulation, a drastic reduction of
[Ca2+ ]i rise was evident not only after stimulation with anti-TCR mAb (Fig . 1 B),
but also after stimulation with anti-CD2 mAbs (Fig . 1 C) . It should be stressed
that CD3-TCR modulation does not affect surface expression of CD2 antigen
(Fig . 1, inset) . Modulation of CD2, on the other hand, had no effect on [Ca
2+],
increase induced byanti-TCR mAb (Fig . 1 E) . It is noteworthy that the treatment
withanti-CD3-TCR mAb did not deplete intracellular stores ofCa2+ , as indicated622
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FIGURE 2 .
￿
Levels of ['HllnsP3 in unmodulated and in CD3-TCR- or CD2-modulated JA3
cells stimulated with anti-TCR or anti-CD2 mAb . In A, unmodulated (9), CD3-TCR-modu-
lated (A), and C132-modulated (M) JA3 cells were stimulated with an anti-TCR mAb . In B,
unmodulated (O), CD3-TCR-modulated (A), and CD2-modulated (0) cells were stimulated
with anti-CD2 mAbs . The indicated times are representative of the intervals from the addition
of the antibody to the lysis of the cells in chloroform/methanol (1 :2) . Data are expressed as
cpm after the substraction of background levels and are representative of three separate
experiments .
by the fact that the response to ionomycin (a calcium ionophore that bypasses
surface receptors) was preserved (data not shown) .
Because it is believed that [Ca2+ ]i increases are mediated by InsPs (formed by
phosphatidylinositol biphosphate [PIP2] hydrolysis) (11, 12), we further examined
whether modulation of CD3-TCR or CD2 molecules also inhibited the increase
of InsPs levels inJA3 cells stimulated with mAbs . In accordance to the data on
[Ca21],' modulation ofCD3-TCR antigens was found to strongly inhibit the InsPs
increase induced by either anti-CD3-TCR or anti-CD2 mAbs (Fig . 2) . On the
other hand, CD2 modulation did not block the InsPs increases stimulated by
anti-CD3-TCR mAbs .
We think it is unlikely that the refractoriness of the cells after CD3-TCR
modulation is due to the persistence of one, or more, of the second messenger
generated by the first stimulus . In fact (a) the levels of InsP s are back to resting
levels in ^-6 h (data not shown), (b) a persistent elevation in protein kinase C
(PKC)activity is unlikely, since it has been demonstrated (13) that anti-CD3 mAb
induces only a transient association with the membranes ofPKC.
An alternative model may explain the general inhibitory effect observed with
anti-CD3-TCR antibodies treatment . It has been suggested that the coupling
between receptors and PIP2 hydrolysis by the specific membrane-bound phos-
phodiesterase is mediated (with different agonists and in different cell types), by
a family of guanine nucleotide binding proteins (G proteins) in a fashion analo-
gous to the coupling of receptors to adenylate cyclase (1, 14) . In human T
lymphocytes, the CD3-TCR complex, but notCD2 molecules may be physically
associated in the membrane with the transducing machinery used by all other
receptors coupled to PIP2 hydrolysis . If this is the case, modulation of the CD3-
TCR complex might result in the concomitant downregulation (or inactivation)
of the associated enzymatic complex, G protein, and/or phosphodiesterase. IfPANTALEO ET AL.
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this hypothesis is correct, not only activation ofsecond messenger generation by
surface receptor stimulation would be inhibited by modulation of CD3-TCR
complex, but also direct activation ofG proteins would be prevented. As recently
demonstrated AIF4- directly activates the G, protein (involved in the activation
of adenylate cyclase) and the G proteins coupled to PIP2 hydrolysis (15, 16).
Preliminary data obtained in our laboratory indicate that modulation ofsurface
CD3-TCR but not of CD2 molecules inhibits the [Ca2+]i and InsPs increases
mediated by AIF4-.
It has been demonstrated that the G proteins coupling the T cell antigen
receptor to the PIP2 phosphodiesterase are inhibited by cholera toxin (17).
Although not shown, cholera toxin also affected the increase ofboth [Ca2']i and
InsPs induced by either anti-CD2 mAbs or AIF4. It is important to note that
similar regulatory mechanisms mediated by the CD3-TCR complex are involved
in the downregulation of CD2-dependent activation pathway also in normal T
lymphocytes (data not shown).
In conclusion, our data demonstrate that the unresponsiveness of T cell that
follows modulation of CD3-TCR complex depends upon a metabolic inhibition
ofthe very early events occurring in response to receptor stimulation. Because
both Ca21 mobilization and inositol metabolism were inhibited, it is likely that
the signal is stopped during its transduction within the plasma membrane. The
hypothesis that the block occurs at the surface receptor levels is not supported
by the finding that in CD3-TCR-modulated T cells, the CD2 pathway was
inhibited in spite of the unchanged expression of CD2 surface molecules. The
preliminary data obtained with AIF4- suggest that the inhibition may occur at
the level of the transducing mechanism and involve the G proteins and/or the
phosphodiesterase.
Summary
We investigatedthe mechanism involvedin T cell unresponsiveness that follows
the monoclonal antibody-induced surface modulation ofthe CD3-TCR complex.
We determined whether modulation of CD3-TCR affected the early metabolic
steps such as [Ca2+]i rise and InsPs formation. Astrong inhibition ofthe increase
on [Ca2+]i mediated by either anti-TCR or anti-CD2 mAbs was detected. In
contrast, surface modulation of CD2 molecules did not prevent the [Ca2+];
increase induced by anti-TCR mAb. Similarly, InsPs increase was strongly
reducedonly aftermodulation ofCD3-TCR complex (but not ofCD2 molecules).
Therefore, it appears that surface modulation ofCD3-TCR complex causes T
cell refractoriness by inhibiting the very early metabolic events that follow
receptor-ligand interactions.
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